© 2026 Optics and Photonics at Nottingham
43%
56.3%
8.8%
£5m+
Data for 2020-2025 from SciVal
Atallah, Edmond; Freixo, Cristiana; Alvarez-Alvarez, Ismael; Cubero, F J; Gerbes, Alexander L; Kullak-Ublick, Gerd A; Aithal, Guruprasad P
Biomarkers of idiosyncratic drug-induced liver injury (DILI) - a systematic review Journal Article
In: Expert Opin. Drug Metab. Toxicol., vol. 17, no. 11, pp. 1327–1343, 2021.
Abstract | Tags: biomarkers, DILI, Drug-induced liver injury, hepatotoxicity, systematic review
@article{Atallah2021-yd,
title = {Biomarkers of idiosyncratic drug-induced liver injury (DILI) -
a systematic review},
author = {Edmond Atallah and Cristiana Freixo and Ismael Alvarez-Alvarez and F J Cubero and Alexander L Gerbes and Gerd A Kullak-Ublick and Guruprasad P Aithal},
year = {2021},
date = {2021-11-01},
journal = {Expert Opin. Drug Metab. Toxicol.},
volume = {17},
number = {11},
pages = {1327\textendash1343},
publisher = {Informa UK Limited},
abstract = {INTRODUCTION: Idiosyncratic drug-induced liver injury (DILI) is
an unpredictable event, and there are no specific biomarkers
that can distinguish DILI from alternative explanations or
predict its clinical outcomes. AREAS COVERED: This systematic
review summarizes the available evidence for all biomarkers
proposed to have a role in the diagnosis or prognosis of DILI.
Following a comprehensive search, we included all types of
studies in humans. We included DILI cases based on any threshold
criteria but excluded intrinsic DILI, commonly caused by
paracetamol overdose. We classified studies into diagnostic and
prognostic categories and assessed their methodological quality.
After reviewing the literature, 14 studies were eligible. EXPERT
OPINION: Diagnostic studies were heterogeneous with regard to
the study population and outcomes measured. Prognostic models
were developed by integrating novel biomarkers, risk scores, and
traditional biomarkers, which increased their prognostic ability
to predict death or transplantation by 6 months. This systematic
review highlights the case of need for non-genetic biomarkers
that distinguish DILI from acute liver injury related to
alternative etiology. Biomarkers with the potential to identify
serious adverse outcomes from acute DILI should be validated in
independent prospective cohorts with a substantial number of
cases.},
keywords = {biomarkers, DILI, Drug-induced liver injury, hepatotoxicity, systematic review},
pubstate = {published},
tppubtype = {article}
}
A part of the University of Nottingham
© 2026 Optics and Photonics at Nottingham. Created for free using WordPress and Kubio